HP and obesity disorder: Other metabolic disorders. Additional evidence suggests that zonulin is associated not only with obesity but also with its metabolic complications, including insulin resistance58, non-alcoholic fatty liver disease73–77, gestational diabetes54,55, hyperlipidemia61, and T2D94,95.